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Agrin regulates rapsyn interaction with surface acetylcholine
receptors, and this underlies cytoskeletal anchoring and
clustering
Abstract
The acetylcholine receptor (AChR)-associated protein rapsyn is essential for neuromuscular synapse
formation and clustering of AChRs, but its mode of action remains unclear. We have investigated
whether agrin, a key nerve-derived synaptogenic factor, influences rapsyn-AChR interactions and how
this affects clustering and cytoskeletal linkage of AChRs. By precipitating AChRs and probing for
associated rapsyn, we found that in denervated diaphragm rapsyn associates with synaptic as well as
with extrasynaptic AChRs showing that rapsyn interacts with unclustered AChRs in vivo. Interestingly,
synaptic AChRs are associated with more rapsyn suggesting that clustering of AChRs may require
increased interaction with rapsyn. In similar experiments in cultured myotubes, rapsyn interacted with
intracellular AChRs and with unclustered AChRs at the cell surface, although surface interactions are
much more prominent. Remarkably, agrin induces recruitment of additional rapsyn to surface AChRs
and clustering of AChRs independently of the secretory pathway. This agrin-induced increase in
rapsyn-AChR interaction strongly correlates with clustering, because staurosporine and herbimycin
blocked both the increase and clustering. Conversely, laminin and calcium induced both increased
rapsyn-AChR interaction and AChR clustering. Finally, time course experiments revealed that the
agrin-induced increase occurs with AChRs that become cytoskeletally linked, and that this precedes
receptor clustering. Thus, we propose that neural agrin controls postsynaptic aggregation of the AChR
by enhancing rapsyn interaction with surface AChRs and inducing cytoskeletal anchoring and that this is
an important precursor step for AChR clustering.
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The acetylcholine receptor (AChR)-associated pro-
tein rapsyn is essential for neuromuscular synapse for-
mation and clustering of AChRs, but its mode of action
remains unclear. We have investigated whether agrin,
a key nerve-derived synaptogenic factor, influences
rapsyn-AChR interactions and how this affects cluster-
ing and cytoskeletal linkage of AChRs. By precipitat-
ing AChRs and probing for associated rapsyn, we
found that in denervated diaphragm rapsyn associates
with synaptic as well as with extrasynaptic AChRs
showing that rapsyn interacts with unclustered AChRs
in vivo. Interestingly, synaptic AChRs are associated
with more rapsyn suggesting that clustering of AChRs
may require increased interaction with rapsyn. In sim-
ilar experiments in cultured myotubes, rapsyn inter-
acted with intracellular AChRs and with unclustered
AChRs at the cell surface, although surface interac-
tions are much more prominent. Remarkably, agrin
induces recruitment of additional rapsyn to surface
AChRs and clustering of AChRs independently of the
secretory pathway. This agrin-induced increase in
rapsyn-AChR interaction strongly correlates with
clustering, because staurosporine and herbimycin
blocked both the increase and clustering. Conversely,
laminin and calcium induced both increased rapsyn-
AChR interaction and AChR clustering. Finally, time
course experiments revealed that the agrin-induced
increase occurs with AChRs that become cytoskel-
etally linked, and that this precedes receptor cluster-
ing. Thus, we propose that neural agrin controls
postsynaptic aggregation of the AChR by enhancing
rapsyn interaction with surface AChRs and inducing
cytoskeletal anchoring and that this is an important
precursor step for AChR clustering.
Clustering of neurotransmitter receptors in the postsynaptic
membrane is a fundamental aspect of synapses and is thought
to originate from receptor interactions with scaffolding pro-
teins that mediate binding to the cytoskeleton. At the neuro-
muscular junction (NMJ),1 the 43-kDa scaffolding protein
rapsyn plays a pivotal role in clustering of acetylcholine recep-
tors (AChRs). This is best illustrated by rapsyn / mice,
which lack differentiated NMJs and fail to cluster both AChRs
and cytoskeleton-interacting components such as utrophin and
dystroglycan (1). Furthermore, mutations in rapsyn can lead to
congenital myasthenic syndrome in humans and gradual loss of
synaptic AChRs (2).
Rapsyn’s mode of action remains unclear, although rapsyn is
sufficient to drive clustering of AChRs upon expression in het-
erologous cells. In these cells rapsyn forms aggregates in the
absence of AChRs and, upon coexpression, colocalizes with
AChRs, MuSK, and -dystroglycan in clusters (3–6). These
observations have led to the concept that rapsyn recruits
AChRs into cytoskeleton-bound clusters, and that rapsyn in-
teracts with AChRs only in clusters (reviewed in Refs. 7 and 8).
In muscle cells, however, several observations indicate that
AChR aggregation is a precisely regulated process. First, AChR
clustering in muscle is regulated by the motor nerve in a
process that requires neural agrin (9). Agrin acts via the recep-
tor tyrosine kinase MuSK, and initiates a signaling mechanism
that leads to rapsyn-dependent AChR clustering (13, 14). Some
spontaneous AChR clusters are still observed in aneural mus-
cle in vivo (10, 12) and in cultured myotubes in vitro, however
(11). Rapsyn colocalizes with these spontaneous clusters in
myotubes (11) and, consistent with this, can also be detected in
complexes with the AChR (15). Secondly, unlike in heterolo-
gous cells, rapsyn does not cluster in the absence of AChRs in
muscle but needs some form of association with the AChR in
order to form aggregates (16, 17). Thirdly, in myotubes, the
relative expression levels of rapsyn and AChRs are critical
parameters for clustering. Transfected myotubes that slightly
overexpress rapsyn form more (although smaller) AChR clus-
ters, whereas strong overexpression of rapsyn abolishes clus-
tering (18, 19). Although these studies establish the impor-
tance of the general rapsyn to AChR expression ratio, they do
not address the ratio and regulation of rapsyn-AChR interac-
tion and the possible importance of this in receptor clustering.
Regulation of AChR-rapsyn interactions could involve secre-
tory mechanisms, because in Torpedo electric organ, rapsyn
and AChRs are co-transported in post-Golgi vesicles suggesting
that the secretory pathway may deliver rapsyn with AChRs to
the plasma membrane (20). It remains unknown, however,
whether rapsyn actually interacts with these intracellular
AChRs and whether the post-Golgi vesicles deliver rapsyn and
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AChRs directly into the postsynaptic membrane or rather into
extrasynaptic membrane areas.
Thus, it is currently unclear where rapsyn interacts with
AChRs within developing mammalian muscle, and whether
rapsyn binds only to clustered receptors or also to unclustered
surface AChRs. It is further unclear how rapsyn-AChR interac-
tions are modulated by agrin in the process of clustering and how
such modulation may contribute to the formation of a cluster.
We have therefore investigated the interaction of rapsyn
with unclustered AChRs at the muscle surface and its regula-
tion by agrin. We find that rapsyn associates with extrasynap-
tic, unclustered surface AChRs, that synaptic AChRs are asso-
ciated with more rapsyn, and that these interactions are much
more prominent than intracellular interactions. Interestingly,
we find that agrin increases the amount of rapsyn associated
with surface AChRs in myotubes in vitro. The agrin-induced
increase in the rapsyn-AChR interaction requires tyrosine ki-
nase activity, occurs independently of the secretory pathway,
parallels the rapid cytoskeletal linkage of AChRs, and corre-
lates highly with the subsequent clustering of the AChR. Thus,
our data suggest that the enhanced interaction of rapsyn with
surface AChRs is a crucial precursor step in the clustering
process triggered by agrin.
EXPERIMENTAL PROCEDURES
Cell Cultures—C2 (C2C12), S26, S27, and Sol8 cell lines were prop-
agated and fused as previously described (21, 22). Constructs encoding
the C-terminal half of neural and muscle agrin isoforms (C-Ag12,4,8 and
C-Ag12,0,0, respectively) were expressed in COS cells as described earlier
(23). To achieve the 20 °C block, myotubes were shifted to Dulbecco’s
modified Eagle’s medium containing 20 mM Hepes, pH 7.5, and incu-
bated at 20 °C either in a cooled water bath or in a cooling incubator. To
inhibit tyrosine kinases, C2 myotubes were preincubated for 5 h with 15
nM staurosporine or 2 M herbimycin A, followed by agrin treatment in
the presence of inhibitors (23).
Rapsyn Antibodies—Two novel antibodies, Rap1 and Rap2, were
produced by Research Genetics (Huntsville, AL) in rabbits against
peptides corresponding to amino acids 133–153 (Rap1) and to the C-
terminal 11 amino acids (Rap2) of mouse rapsyn. Rap1 and Rap2, but
not their preimmune sera, recognize rapsyn as a single band of 43 kDa
in immunoblots made from biotinylated -bungarotoxin (-BT) AChR
precipitations; no signal is seen when excess free -BT was included in
the precipitation (Fig. 1 and data not shown). After affinity purification
using the immunizing peptides, both Rap1 and Rap2 recognize rapsyn
as a major band of 43 kDa in immunoblots made from whole cell
extracts of C2 myotubes or rat diaphragm muscle (Figs. 1 and 2 and
data not shown). In immunostainings, affinity-purified Rap2 specifi-
cally recognizes rapsyn in clusters in C2 but not in rapsyn / myo-
tubes (15) and at NMJs in rat diaphragm sections (Fig. 2 and data not
shown). The reactivities of Rap1 and Rap2 in immunoblots allowed
detection with higher sensitivity than antibodies 5943p and mAb1234,
well characterized rapsyn antibodies that we obtained from Dr. J. S.
Sanes (Washington University, St. Louis, MO) and Dr. S. C. Froehner
(University of Washington, Seattle), respectively.
Preparation of Diaphragms—Diaphragms were removed from decap-
itated adult Wistar rats of at least 150 g body weight. For denervation,
rats (6 in total) were anesthetized with isoflurane and the left phrenic
nerve innervating the left hemi-diaphragm was cut. 5–6 days later,
diaphragms were removed. From both denervated and control animals,
synaptic areas of the left hemi-diaphragm were microscopically dis-
sected from extrasynaptic areas, by observing the location of the nerve
and by using AChEsterase staining of parallel control samples. From
each preparation a control piece (4–5 mm wide) was analyzed by serial
8-m thick transverse or longitudinal cryosectioning followed by rho-
damine--BT staining. The control piece had the same width as the
main piece and, in case of extrasynaptic preparations, stretched from
the medial to the lateral edges of the diaphragm muscle. This procedure
revealed many AChR clusters in synaptic, but none in extrasynaptic
areas both in normal and denervated animals. The main diaphragm
pieces were extracted and subjected to immunoblotting or
-BT-precipitation.
Immunocytochemical Staining—Secondary antibodies were pur-
chased from Jackson ImmunoResearch Laboratories (La Roche, Swit-
zerland) unless stated otherwise. C2 or S27 myotubes were fixed in 2%
paraformaldehyde and 11% sucrose or in methanol at 20 °C. Follow-
ing permeabilization in blocking buffer (5% normal goat serum (NGS)
and 0.1% Triton X-100 in phosphate-buffered saline), 100 nM tetra-
methylrhodamine-conjugated -BT (Molecular Probes, Eugene, OR),
and antibodies were applied in blocking buffer. Rapsyn was detected
with mAb1234 followed by fluorescein isothiocyanate-conjugated goat
anti-mouse secondary antibodies.
Diaphragm sections were blocked by 5% NGS in phosphate-buffered
saline, followed by incubation with affinity-purified Rap2 antibodies and
Alexa 488-conjugated -BT (Molecular Probes) in the same buffer. Sec-
tions were then incubated with Alexa 546-conjugated goat anti-rabbit
secondary antibodies (Molecular Probes) and Alexa 488-conjugated -BT,
all in 5% NGS/phosphate-buffered saline. Cells or sections were mounted
in a solution containing glycerol and p-phenyldiamine to reduce fading
and examined by fluorescence microscopy as described earlier (17).
Isolation of AChR Complexes and Immunoblotting—Total AChRs
(i.e. receptors representing the total cellular pool of AChRs) were iso-
lated from myotube lysates using -BT-conjugated Sepharose beads or
soluble biotin-conjugated -BT followed by streptavidin-coupled aga-
rose beads (Molecular Probes) as described previously (21). To precipi-
tate surface AChRs, intact myotubes were incubated with 200 nM bio-
tin--BT for 1 h at 4 °C. After washing, cells were lysed and AChRs
isolated by adding streptavidin-coupled agarose beads. For precipita-
tion of intracellular receptors, surface AChRs were first blocked by
incubation of intact cells with 0.5 M free -BT for 1 h at 37 °C. After
washing, cells were lysed and incubated with biotin-conjugated -BT
followed by streptavidin-coupled agarose beads. In control experiments
we added an excess (10 M) of free -BT prior to biotin--BT, or used
unconjugated Sepharose. We also determined that 0.5 M free toxin is
sufficient to block surface AChRs (data not shown).
To isolate total AChRs from diaphragms, tissue from two animals
was pooled and homogenized in lysis buffer without detergent, using a
tight fitting Dounce homogenizer. After adding detergent, samples were
processed as detailed for myotubes above.
Blotting procedures and detection of precipitated AChR  and 
subunits were as described earlier (15, 22). AChR-bound or total cellu-
lar rapsyn was detected using Rap1 or occasionally 5943p antibodies.
Immunoblot quantitation was performed by scanning films with a com-
puterized densitometer (Nikon Scantouch 210, Japan) and using the
NIH Image J 1.04b software (NIH, Bethesda, MD). To quantitate the
amount of rapsyn associated with precipitated AChRs (rapsyn on
AChRs, Figs. 2–7) signals for rapsyn co-precipitated with AChRs (total,
surface or intracellular) were normalized for the amount of AChR
isolated (as revealed by AChR  immunoblotting).
Extractability Assays—Cytoskeletal linkage of surface AChRs in Sol8
cells was assayed exactly as described previously (22). Briefly, cells were
scraped off in buffer lacking detergent and pelleted by centrifugation.
Pellets were then first extracted with low detergent buffer (0.5% Triton
X-100 for 10 min at 4 °C), followed by centrifugation and re-extraction of
the insoluble pellet in high detergent buffer (1% Triton X-100 for another
10 min). From the supernatant of each extraction, surface AChRs labeled
with biotin--BT were isolated using streptavidin beads.
This method was adapted for differential extraction of C2 myotubes.
Here, a first extraction buffer (15), containing 0.05% Nonidet P-40, was
added directly to cells in the culture dishes, and cells were extracted at
4 °C for 21 min. After centrifugation at 18,000 g for 3 min at 4 °C, the
insoluble pellet was re-extracted in a second extraction buffer contain-
ing 1% Nonidet P-40 for 15 min at 4 °C, followed by re-centrifugation.
From the supernatant of each extraction, total AChRs were isolated
using biotin--BT as described in the previous paragraph.
In both methods, the sum of AChRs from the two fractions was con-
stant irrespective of agrin treatment (100%, Fig. 8b, left), whereas the
sum of AChR-bound rapsyn was increased due to agrin (171%, Fig. 8b,
right). Rapsyn was predominantly associated with AChRs isolated from
the 1% detergent fraction in both methods (compare Fig. 8, a versus c).
RESULTS
Characterization of Rapsyn Antibodies—To investigate the as-
sociation of rapsyn with the AChR, we first aimed at developing
sensitive tools to visualize rapsyn-AChR interactions and there-
fore raised two polyclonal antibodies against different domains of
rapsyn (see “Experimental Procedures”), Rap1 and Rap2. We
first tested the specificity of these antibodies by precipitating
total AChRs from lysates of C2 myotubes using -BT followed by
streptavidin-agarose as previously described (21). AChR-bound
rapsyn was then analyzed by Western blotting with Rap1 or
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Rap2 antisera. Both antibodies, but not their preimmune sera,
identified a single band corresponding to rapsyn that was co-
precipitated with AChRs (Fig. 1a; data for Rap2 not shown).
Precipitation of the AChR was confirmed by reprobing the blots
with antibodies against the AChR -subunit (Fig. 1a, bottom
panels). In addition, Western blotting with Rap1 antisera, after
precipitating AChRs with an antibody against the AChR  sub-
unit (mAb35), identified a similar prominent band corresponding
to rapsyn (see Fig. 4c). Immunoblot analysis of C2 lysates with-
out AChR precipitation showed that affinity-purified Rap1 and
Rap2, but not the crude sera, identify a single band at the mo-
lecular weight of rapsyn (Fig. 1b).
Thus, Rap1 and Rap2 antibodies allow specific and efficient
detection, by immunoblotting, of AChR-associated rapsyn and
total cellular rapsyn in cultured myotubes. The sensitivity of
this detection appears much higher than in our previous stud-
ies using other rapsyn antibodies (15), enabling us now to
detect subtle changes in the rapsyn-AChR interaction.
Synaptic AChRs Interact with More Rapsyn than Extrasyn-
aptic AChRs in Vivo—Rapsyn interacts with the receptor in
cultured myotubes not treated with agrin (Fig. 1 and Ref. 15),
but it is unclear whether this association occurs only with
AChR in spontaneous clusters or also with unclustered AChR
(15). To investigate this question, we first studied rapsyn-
AChR interaction in extrasynaptic versus synaptic areas of
diaphragms of adult rats. Extrasynaptic and synaptic areas
were microscopically dissected and divided into two parts. The
smaller control parts were cryostat sectioned and serial trans-
verse or longitudinal sections throughout the piece of tissue
were double-labeled for AChRs and rapsyn using the affinity-
purified Rap2 anti-rapsyn antiserum. This showed that synap-
tic preparations are rich in co-localizing clusters of AChRs and
rapsyn (Fig. 2a). Extrasynaptic preparations, in contrast, were
completely devoid of clustered AChRs and rapsyn along the
whole length of these preparations, stretching from the medial
to the lateral edges of the diaphragm muscle (Fig. 2a).
The major parts of the synaptic and extrasynaptic prepara-
tions were lysed and AChRs precipitated using biotin--BT.
Immunoblotting with Rap1 revealed that rapsyn interacts with
synaptic AChRs (Fig. 2c). The low amounts of extrasynaptic
AChR and rapsyn (see Fig. 2b) prohibited assessment of a
possible interaction of the two proteins in these regions. There-
fore, we denervated the left hemi-diaphragm, leaving the right
hemi-diaphragm intact. Western blot analysis 5 days after
denervation showed that rapsyn and AChRs were up-regulated
in lysates made from extrasynaptic areas of the denervated left
hemi-diaphragm but not in lysates from extrasynaptic inner-
vated diaphragm (Fig. 2b). The extent of up-regulation was
higher for AChRs than for rapsyn, in agreement with the
different degree of up-regulation of their respective mRNAs
after denervation (24). This up-regulation, however, was not
sufficient to allow immunohistochemical detection of AChRs
and rapsyn in extrasynaptic areas of denervated hemi-dia-
phragm (data not shown). Importantly, clusters of AChRs and
rapsyn were never observed in these denervated extrasynaptic
preparations, either. In fact, immunostainings for rapsyn and
AChRs of denervated extrasynaptic areas yielded results indis-
tinguishable from those of innervated extrasynaptic areas as
shown in Fig. 2a.
Precipitation of total AChRs from these denervated dia-
phragms showed that rapsyn was associated with AChRs in both
extrasynaptic and synaptic areas (Fig. 2d). Interestingly, signif-
icantly more rapsyn (73.9 2.8% more) was co-precipitated with
AChRs from synaptic than from extrasynaptic areas, although
the amounts of isolated AChR were equal (Fig. 2e). These data
demonstrate that rapsyn interacts with unclustered AChRs in
extrasynaptic areas of the diaphragm muscle in vivo. However,
synaptic AChR-rapsyn interactions are more pronounced, be-
cause AChRs isolated from muscle areas that contain synapti-
cally clustered AChRs are bound to more rapsyn.
Rapsyn Interacts with Unclustered Surface AChRs in Cul-
tured Myotubes—The observed interaction of rapsyn with ex-
trasynaptic AChRs in vivo may be due to interactions of rapsyn
with intracellular AChRs and/or unclustered receptors at the
cell surface. To investigate this question, we first tested
whether rapsyn interacts with unclustered AChRs at the cell
surface using myotube cultures of non-agrin-treated C2 cells,
as well as two proteoglycan mutants derived from C2, S27, and
S26. In contrast to C2, S27 and S26 cells completely lack
spontaneous clusters of rapsyn and AChRs, and these proteins
are therefore distributed in a diffuse, unclustered manner in
these two cell lines (Fig. 3a and Ref. 11). We isolated total
AChRs from myotube extracts using -BT, and then immuno-
blotted for bound rapsyn. We found that comparable amounts
of rapsyn were co-precipitated with receptors in non-agrin-
treated C2, S26, and S27 cells (Fig. 3, b and c). These results
demonstrate that rapsyn interacts with unclustered AChRs in
cultured myotubes.
FIG. 1. Characterization of rapsyn antibodies and precipita-
tion of AChRs. a, AChRs, reflecting the total pool, were precipitated
from lysates of C2 myotubes using biotin--BT (Tox-P) and AChR-
bound rapsyn was visualized by immunoblotting with Rap1 (Rap1 blot;
left panel). In controls, preimmune serum was used (right panel) or 10
M free -BT was added (T) or biotin--BT was omitted (SB). Blots
were reprobed with AChR -subunit-specific antisera (lower panels).
Rap1 specifically detects AChR-bound rapsyn. b, lysates from C2 myo-
tubes were analyzed by immunoblotting using Rap1 and Rap2 crude
sera (ser) or affinity-purified antibodies (pur). Purified Rap1 and Rap2
recognize a single band corresponding to rapsyn.
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Second, we tested whether rapsyn interacts with intracellu-
lar and/or surface AChRs. For this purpose, we separately
precipitated either surface or intracellular AChRs (22), and
analyzed bound rapsyn by Rap1-immunoblotting. In order to
precipitate surface AChRs, intact myotube cultures were incu-
bated with biotinylated -BT. After washing and lysis of the
cells, surface AChRs were isolated by adding streptavidin-
agarose. Intracellular AChRs, in contrast, were isolated with
biotinylated -BT and streptavidin-agarose after surface
AChRs were first blocked with free -BT. In each case, precip-
itated AChRs were detected by immunoblotting for the AChR
-subunit, and AChR-bound rapsyn was detected using Rap1
antibodies. Probing for the AChR revealed that the majority of
the receptor is located at the plasma membrane with only a
relatively small fraction of all AChRs located intracellularly.
Furthermore, the surface and intracellular AChRs pools were
additive to yield total AChRs (data not shown).
We next found that, although rapsyn co-precipitated with
both surface and intracellular AChRs, it was preferentially
associated with the surface receptor pool. Thus in C2, the size
of the intracellular AChR pool is 40% of the surface receptor
pool, but the amount of rapsyn bound to intracellular AChRs is
only 10% of the amount of rapsyn bound to surface AChRs
(Fig. 3, d and e). S27 yielded similar results (Fig. 3, d and e).
Rapsyn therefore interacts with intracellular receptors, but the
average amount of rapsyn bound per AChR is much lower
intracellularly than at the surface.
Taken together, these findings indicate that rapsyn predom-
inantly associates with surface AChRs. In addition, the S27
data indicate that rapsyn interacts efficiently with unclustered
AChRs. Since the level of rapsyn-AChR interaction is very
similar for S27 and C2, this suggests that in non-agrin-treated
C2, the majority of rapsyn-AChR-complexes are unclustered.
Neural Agrin Increases the Interaction of Rapsyn with the
AChR, and This Precedes and Correlates with Clustering—We
show that, in diaphragm, synaptic AChRs interact with more
rapsyn than unclustered extrasynaptic AChRs (Fig. 2). To in-
vestigate whether this difference is caused by neurally derived
agrin, which is concentrated at NMJs (25), we treated C2
myotubes with recombinant neural agrin and determined the
amount of rapsyn co-precipitated with total AChRs by Western
blotting with the Rap1 antiserum. Neural agrin indeed caused
an increase in the amount of rapsyn bound to AChRs (Fig. 4a).
A similar increase in the rapsyn-AChR interaction was seen
FIG. 2. Rapsyn is associated with
extrasynaptic AChRs in vivo, al-
though to a lesser degree than with
synaptic receptors. a, cross-sections of
synaptic (Syn) and extrasynaptic (Xtra)
areas of rat diaphragm were double-la-
beled with Alexa 488--BT (green) and
Rap2 antibodies followed by Alexa 546-
conjugated secondary antibodies (red).
AChRs and rapsyn co-localize at NMJs
(yellow) but are not detectable extrasyn-
aptically. Scale bar, 30 m. b, equal pro-
teins amounts from lysates of extrasynap-
tic areas of innervated (In) or denervated
(Den) diaphragms were analyzed by im-
munoblotting using antibodies against
rapsyn (Rap1) or the AChR -subunit. c
and d, total AChRs were precipitated
from extrasynaptic (Xtra) or synaptic
(Syn) areas of innervated (c) or dener-
vated (d) diaphragms using biotin--BT
(Tox-P), followed by rapsyn and AChR 
immunoblotting. e, quantitation of blots
as in d shows that in denervated dia-
phragm, more rapsyn is associated per
AChR (70% more) in synaptic than in
extrasynaptic areas. Extra. Den., extra-
synaptic denervated. Data represent
mean  S.D. of three experiments. **,
differs significantly from Extra. Den. p 
0.01 by two-tailed Student’s paired t test.
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when -BT-precipitated total AChRs were probed with another
rapsyn antibody (5943p) to detect AChR-bound rapsyn (Fig.
4b). Furthermore, isolation of total AChRs by immunoprecipi-
tation with an antibody against the AChR -subunit (mAb35),
followed by Rap1 immunoblotting, revealed a comparable
agrin-induced increase in the rapsyn-AChR interaction (Fig.
4c). Finally, this increase is specific for neural agrin since
treatment with muscle agrin isoforms had no effect (Fig. 4d).
We next quantitated this increased interaction in response to
neural agrin and determined its dose-dependence and time
course. Treatment of C2 myotubes with a low concentration
(100 pM) of neural agrin for 1 h was sufficient to cause a
maximal increase, 70%, in the amount of rapsyn bound to
total AChRs (Fig. 5a). In time course experiments, this increase
occurred rapidly, reached its maximum within 40 min of neural
agrin treatment and stayed elevated thereafter (Fig. 5b).
Taken together, these data show that neural agrin rapidly
increases the amount of rapsyn associated with AChRs, and
that this precedes clustering of the AChR which is first detect-
able after 4 h of agrin treatment (26).
To investigate the significance of the increase in rapsyn-
AChR interaction for clustering of the AChR, we treated C2
myotube cultures with herbimycin and staurosporine, two ty-
rosine kinase inhibitors that prevent agrin-induced AChR clus-
tering (26). Assessment of the amount of rapsyn co-precipitated
with total AChRs revealed that both inhibitors attenuated the
agrin-induced increase in rapsyn-AChR association without
affecting the pre-existing interaction (Fig. 6a). In addition, we
used S27 myotubes, which are not able to form AChRs clusters
in response to even high concentrations of agrin (26). In these
cells, agrin did not affect rapsyn-AChR association, not even at
50 nM (Fig. 6b and data not shown).
If the increase in rapsyn-AChR interaction is required for
clustering, one can expect that induction of clustering by alter-
native agents and pathways will induce a similar increase in
the interaction. Therefore, we treated C2 myotubes with Ca2
or laminin-1. These treatments induce AChR aggregation in
myotubes although through different mechanisms because
Ca2 causes phosphorylation of MuSK while laminin does not
(27–29). Laminin, nevertheless, requires rapsyn and the activ-
ity of downstream tyrosine kinases to induce AChR clustering
in myotubes (30). In our experiments, both Ca2 and laminin
elicited a clear increase in the amount of rapsyn co-precipitated
with total AChR, and this increase was comparable to the
increase triggered by agrin (Fig. 6c).
These results demonstrate a strong correlation between in-
creased rapsyn-AChR interaction and clustering of these pro-
teins, suggesting that this is a common required precursor step
in formation of AChR clusters in muscle.
Agrin-induced Increase in Rapsyn-AChR Interaction Occurs
at the Cell Surface and Is Independent of the Secretory Path-
way—Since rapsyn interacts predominantly with AChRs at the
surface, we next examined whether the agrin-induced increase
in interaction occurs with surface AChRs. Agrin treatment of
C2 myotubes followed by selective precipitation of surface
AChRs revealed that agrin indeed increases the interaction of
rapsyn with surface AChRs (Fig. 7b). The extent of this in-
crease was identical to the increase in association of rapsyn
with total AChRs (see Fig. 5). Furthermore, precipitating in-
tracellular AChRs after agrin treatment did not reveal an
increase in rapsyn-intracellular AChR interaction showing
that agrin specifically increases the association of rapsyn with
FIG. 3. Intracellular and unclus-
tered AChRs at the surface of myo-
tubes interact with rapsyn. a, double
labeling with rhodamine--BT and
rapsyn antibodies (mAb1234) shows that
spontaneous clusters of AChRs and
rapsyn are absent in S27 but present in
C2 myotubes. Photographic exposure
times for S27 were 3-fold longer than for
C2. Scale bar, 20 m. b and c, -BT-
Sepharose precipitation of total AChRs,
followed by rapsyn (5943p antibodies) and
AChR immunoblotting, shows that
rapsyn is equally associated with AChRs
in C2, S26, and S27 myotubes. As con-
trols, 10 M free -BT was added (T),
unconjugated Sepharose was used (CS),
and a fraction of the starting lysate was
analyzed (L). Quantitation represents
mean  S.E. of six experiments; values
for S26 and S27 were combined. d, surface
and intracellular AChRs were isolated
from C2 using biotin--BT, followed by
rapsyn and AChR  immunoblotting; one-
fifth of the surface precipitation was
loaded to allow comparison. e, for quanti-
tation of blots as in d, values of surface
AChRs and of rapsyn bound to surface
AChRs were set to 100%, and intracellu-
lar values were calculated accordingly.
Data represent mean  S.D. of four ex-
periments. *, differs significantly from in-
tracellular AChRs (p  0.05 by two-tailed
Student’s paired t test), indicating that
rapsyn associates to a higher degree with
surface than with intracellular AChRs.
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surface AChRs (data not shown).
It has been proposed that rapsyn and AChRs are co-trans-
ported through the secretory pathway to the postsynaptic ap-
paratus in Torpedo electrocytes (20, 31). This, together with
our observed intracellular rapsyn-AChR complexes (Fig. 3),
raised the question of whether the secretory pathway may
contribute to the agrin-induced increase in rapsyn-surface
AChR interaction and to AChR clustering. To assess the role of
the secretory pathway in these processes, we first established
the effect of 20 °C incubation on AChR surface delivery. This
temperature selectively blocks formation of post-Golgi trans-
port vesicles, results in accumulation of newly made plasma
membrane proteins in the trans-Golgi network (TGN) and
therefore prevents surface delivery of AChRs (32). C2 myotubes
were incubated with free -BT to block pre-existing surface
AChRs, followed by biotin--BT to identify newly inserted sur-
face receptors (Fig. 7a). At 37 °C new AChRs were readily
detected while at 20 °C insertion of receptors was inhibited
(Fig. 7a, lane 1), even when this temperature was only applied
during the biotin--BT incubation. These data show that a 1-h
incubation at 20 °C is sufficient to block transport of the AChR
from the TGN to the surface in our myotube cultures. This
temperature is thus a useful tool to specifically block the se-
cretory pathway at the level of the TGN.
We found that application of agrin at 20 °C still increased the
interaction of rapsyn with surface AChRs as assessed by selec-
tive precipitation of surface AChRs, showing that this increase
does not depend on surface delivery via the secretory pathway
(Fig. 7b). Furthermore, incubation at 20 °C did not affect the
amount of pre-existing surface AChR-rapsyn complexes, whose
short time maintenance thus does not depend on an intact
secretory pathway. At 20 °C, prolonged agrin treatment in-
duced AChR clustering to a comparable degree as observed in
control cultures at 37 °C (Fig. 7, c and d). However, clustering
at 20 °C proceeds slower than at 37 °C because 7 h of agrin
treatment at 20 °C were not sufficient to induce clusters (data
not shown). AChR clusters formed at 20 °C were in general
smaller, thinner and less intense in appearance than at 37 °C,
which is presumably due to a loss of AChRs from the surface
FIG. 4. Neural agrin increases the interaction of rapsyn with
AChRs in C2 myotubes. a and b, total AChRs were precipitated from
myotube cultures treated with neural agrin (0.25 nM) for 1 h or from
control cultures. AChR-bound rapsyn was visualized by immunoblot-
ting with Rap1 (a) or 5943p (b) followed by reprobing with AChR
-subunit-specific antisera. c, alternatively, total AChRs were immu-
noprecipitated with antibodies against the AChR  subunit (mAb35)
followed by immunoblotting with Rap1 and reprobing with AChR /-
subunit-specific antisera (mAb 88b). As controls, the mAb35 antibody
was omitted from the precipitation (No Ab) or the myotube lysate was
omitted (LB). The amount of rapsyn per AChR in neural agrin-treated
cultures is higher than in control cultures. d, muscle agrin (0.25 nM)
was applied overnight, followed by the same procedure as in a. Muscle
agrin does not increase the rapsyn-AChR interaction. Data represent
mean  S.D. of at least three experiments.
FIG. 5. Dose and time-dependence of the agrin-induced in-
crease in rapsyn-AChR interaction. a, myotubes were treated with
increasing concentrations of agrin (neural isoform) for 1 h. Precipitation
of total AChRs was followed by rapsyn and AChR immunoblotting. The
amount of rapsyn bound to total AChRs was quantitated (lower panel).
100 pM of agrin is sufficient to elicit a 70% increase in the rapsyn-
receptor interaction. b, neural agrin (0.25 nM) was applied for increas-
ing times, and AChR-bound rapsyn was analyzed as in a. Neural agrin
causes maximal increase in rapsyn-receptor interaction within 40 min.
This increase does not decline thereafter. Data represent mean  S.D.
of at least three experiments. Significant differences from controls: *,
p  0.05; **, p  0.01, by two-tailed Student’s paired t test.
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since only exocytosis but not endocytosis is blocked at 20 °C.
These data demonstrate that the secretory pathway is not
required for agrin-induced clustering of pre-existing surface
AChRs, and that the events critical for clustering thus occur at
the cell surface. Together, the results show that agrin causes
an increase in the interaction of rapsyn with surface AChRs
independently of the secretory pathway, and this increase in
itself appears sufficient for clustering in the absence of
secretion.
Rapsyn Interaction Correlates with Linkage of the AChR to
the Cytoskeleton—In the clustering process triggered by agrin,
AChRs become linked to the cytoskeleton (33). We analyzed
whether the increased rapsyn-AChR interaction following
agrin treatment might mediate this anchoring. In cultured
myotubes, cytoskeletal linkage of AChRs can be assayed by a
differential extraction procedure in which AChRs are first ex-
tracted in a low detergent buffer, followed by re-extraction of
insoluble receptors in a higher detergent buffer. Surface
AChRs are then precipitated separately from these extractions
using biotin--BT (22). In cultured Sol8 myotubes, a 1-h agrin
treatment induced a decrease in the amount of surface AChR
that was extracted in low detergent, with more receptor being
shifted to the less extractable, cytoskeletal-associated fraction
(Fig. 8, a and b). Strikingly, rapsyn was predominantly associ-
ated with AChRs in the less extractable fraction, and the agrin-
induced increase (71%; see also Fig. 5) in rapsyn-AChR inter-
action occurred predominantly with the less extractable AChR
pool (Fig. 8, a and b). Similar results were obtained following
agrin treatment of C2 myotubes, in which the majority of newly
recruited rapsyn molecules were also bound to less extractable
AChRs (Fig. 8, c and d). Finally, time course experiments in
Sol8 myotubes showed that the shift in extractability of the
AChR occurring after 1 h of agrin treatment (Fig. 8a) was
maintained at 6 and 24 h of agrin treatment.2 The agrin-
2 L. S. Borges and M. J. Ferns, unpublished data.
FIG. 6. Increased rapsyn-AChR interaction correlates with
clustering. Total AChRs were precipitated from C2 myotubes, and
receptor-bound rapsyn detected by Rap1-immunoblotting. a, herbimy-
cin (Herb) and staurosporine (Stau) inhibit the agrin-induced increase
in rapsyn-AChR association in C2 cells (0.25 nM agrin for 1 h). b, in S27
myotubes, 0.25 nM agrin does not affect rapsyn-AChR interaction. c,
increased rapsyn-receptor associations are observed after treatment of
C2 with Ca2 (5 mM overnight) or laminin (100 nM overnight, Lm),
conditions that induce AChR clustering (not shown). Data are mean 
S.D. from at least three experiments. Significant differences from con-
trols: *, p  0.05; **, p  0.01; by two-tailed Student’s paired t test.
FIG. 7. Agrin increases the interaction of rapsyn with surface
AChRs and causes AChR clustering independently of the secre-
tory pathway. a, C2 myotubes were incubated for 1 h at 20 °C or 37 °C
with free -BT (Tx), followed by 1 h with biotin--BT (biotin Tx) at the
indicated temperature. Surface AChRs were isolated with streptavidin-
Sepharose and visualized by AChR  immunoblotting. At 20 °C, surface
transport of newly synthesized AChRs is blocked within 1 h. b, C2
myotubes were incubated with 0.25 nM agrin at 37 °C or 20 °C for the
indicated times; agrin was added 1 h after the shift to 20 °C. Surface
AChRs were isolated, subjected to rapsyn and AChR-immunoblotting,
and rapsyn bound to AChRs quantified, using untreated cells (black
bar) as controls. Agrin increases this interaction at the surface, even
when surface delivery of AChRs is blocked by shifting the myotubes to
20 °C. c, C2 myotubes were treated with 0.25 nM agrin for 20 h at 20 °C
or 37 °C, and AChRs were visualized with rhodamine--BT. d, the
average number of AChR clusters per myotube was determined by
counting clusters (as shown in c) in 20 visual fields per treatment. Agrin
increases the number of AChR clusters significantly even at 20 °C,
although these clusters have a thinner and less bright appearance.
Data represent mean  S.D. from at least three experiments. Signifi-
cant difference from control: *, p  0.05; **, p  0.01; ***, p  0.001; by
two-tailed Student’s paired t test.
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induced decrease in extractability of the AChR therefore par-
allels the kinetics of the increase in rapsyn-AChR interaction
(see Fig. 5b).
These data demonstrate that rapsyn-associated AChRs are
preferentially linked to the cytoskeleton and that the agrin-
induced increase in rapsyn-AChR interaction correlates highly
with decreased extractability and increased cytoskeletal an-
choring of the AChR. This strongly suggests that increased
rapsyn interaction with surface AChRs may mediate the agrin-
induced anchoring of the receptor that precedes clustering.
DISCUSSION
In this study, we have investigated how rapsyn-AChR inter-
actions relate to clustering. We show that, in vivo, extrasynap-
tic (unclustered) AChRs are associated with rapsyn and that
synaptic AChRs are associated with more rapsyn. We therefore
investigated how rapsyn-AChR interactions are regulated in
myotube cultures, and find that neural agrin rapidly induces
an increase in the interaction of rapsyn with surface AChRs.
This increase requires tyrosine kinase activity, parallels en-
hanced cytoskeletal linkage of the AChR, correlates strongly
with subsequent receptor clustering, and (along with cluster-
ing) occurs independently of the secretory pathway. These ob-
servations suggest that agrin-induced increases in rapsyn-
AChR interactions trigger cytoskeletal anchoring and clus-
tering of AChRs.
Rapsyn and the AChR Form Pre-assembled Complexes—A
long-standing question in synapse formation concerns the se-
quence of events in which postsynaptic components are assem-
bled. At the NMJ much evidence suggests that MuSK forms a
primary synaptic scaffold to which rapsyn is recruited followed
by AChRs and other proteins, implying that rapsyn interacts
with AChRs only in clusters at the synapse (7, 8). However, we
recently reported that, in cultured C2 myotubes that were not
treated with agrin, AChRs already interact with several
postsynaptic proteins including rapsyn (15). Such interactions
may have originated from spontaneously clustered AChRs or
from diffusely distributed receptors. We investigated this issue
and show here that rapsyn interacts with unclustered AChRs
at the surface of S27 myotubes, a mutant derivative of C2 that
completely lacks clusters. The comparable extent of the rapsyn-
receptor interaction between C2, S26, and S27 cells strongly
suggests that the majority of surface AChR-rapsyn complexes
in non-agrin-treated C2 are unclustered. We also find that
rapsyn interacts with unclustered AChRs in diaphragm in vivo.
Based upon the predominant association of rapsyn with surface
AChRs in C2 and S27 myotubes, it seems likely that the extra-
synaptic rapsyn-AChR complexes in diaphragm reside at the
plasma membrane rather than intracellularly. Taken together,
these data show for the first time that rapsyn interacts with
AChRs outside of clusters in pre-assembled, diffusely distrib-
uted complexes, both in cultured myotubes and in diaphragm
muscle.
These unclustered, pre-assembled surface complexes appear
to be important for clustering for the following reasons: Firstly,
rapsyn does not aggregate in the absence of AChRs in ectopi-
cally injected myofibers in vivo (17). Secondly, we recently
estimated that in cultured C2 myotubes 50% of total cellular
rapsyn are constitutively bound to AChRs while the residual
50% represent free rapsyn (17), indicating that pre-assembled
rapsyn-AChR complexes are very prominent. The pool of free
FIG. 8. Rapsyn interaction corre-
lates with cytoskeletal linkage of the
AChR. a, Sol8 myotubes were treated for
1 h with 0.5 nM agrin and extracted first
in 0.5% and then in 1% Triton X-100. Sur-
face AChRs were isolated separately from
these extractions using biotin--BT and
analyzed by AChR  subunit- and rapsyn-
immunoblotting. b, quantitation of the
proportion of AChR recovered in each ex-
traction (a) shows that agrin causes a
shift of receptors from 0.5 to 1% Triton
X-100, indicative of a cytoskeletal link
(left). Rapsyn, before and after agrin
treatment, is predominantly associated
with the less extractable AChRs (1% Tri-
ton X-100; right). Data represent mean 
S.E. of five experiments. Significant dif-
ferences: *, p  0.02 by paired Student’s t
test. c, differential extraction of AChRs
from agrin-treated and untreated C2
myotubes shows that rapsyn is predomi-
nantly associated with less extractable
AChRs. d, In C2 cells, the total agrin-
induced increase in rapsyn binding to all
isolated AChRs (72%), was set to 100%,
and the percentages of newly recruited
rapsyn molecules were calculated for the
more extractable (0.05% detergent) and
less extractable (1% detergent) AChRs.
Thus, agrin-induced rapsyn-AChR com-
plexes are preferentially linked to the cy-
toskeleton. Data are mean  S.D. of five
experiments. *, differs significantly from
low-detergent extraction (p  0.02, by
two-tailed Student’s paired t test).
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rapsyn, which remains after treating C2 myotubes with AChR-
antibodies to down-regulate surface AChRs and surface AChR-
rapsyn complexes, is unable to form aggregates in response to
agrin (17). This illustrates that rapsyn requires some kind of
constitutive association with the AChR for subsequent cluster-
ing driven by agrin in C2 myotubes. Our experiments shown
here demonstrate that constitutive rapsyn-AChR interactions
mostly occur with unclustered AChRs at the surface. Thus, the
antibody treatment by Ref. 17 down-regulated mostly unclus-
tered AChRs and unclustered AChR-rapsyn complexes. There-
fore, our present results, combined with these earlier studies,
indicate that rapsyn is extensively pre-assembled with unclus-
tered surface AChRs in non-agrin-treated C2 myotubes (Fig. 9,
step 1), and that this pre-assembly is necessary for subsequent
clustering of rapsyn and AChRs in response to agrin.
We find that rapsyn also interacts with intracellular AChRs.
The much lower extent of the intracellular association implies
that rapsyn interacts with only a subpopulation of intracellular
AChRs. In support of this idea are the co-localization of rapsyn
and AChRs in post-Golgi transport vesicles, the association of
some rapsyn with the Golgi in Torpedo electrocytes (20), and
our preliminary results that rapsyn is preferentially associated
with AChRs late in the secretory pathway, at the level of late
Golgi or TGN.3 The intracellular interaction may facilitate
AChR and/or rapsyn exocytosis, a hypothesis we are currently
investigating.
Agrin Increases the Interaction of Rapsyn with Surface
AChRs, and This Correlates with AChR Clustering and An-
choring—We show that in denervated muscle fibers in vivo, in
which agrin remains concentrated at NMJs (25), AChRs iso-
lated from synaptic areas have more (70%) rapsyn associated
than extrasynaptic AChRs. The higher amount of rapsyn
bound to synaptic AChRs most likely stems from the action of
motorneuron-derived agrin, as we find that neural agrin elicits
the same increase in rapsyn-AChR interaction in cultured myo-
tubes. The agrin-induced increase in interaction occurred only
on surface AChR and was not blocked at 20 °C, indicating that
it does not require the secretory pathway. At 20 °C, AChRs
were clustered in response to agrin, albeit in less densely
packed aggregates, showing that clustering per se does not
depend on continuous surface delivery of rapsyn and AChRs.
The functional relevance of co-transport of rapsyn and AChR
through the secretory pathway (20, 31) thus remains to be
established. While it may maintain a high density of pre-
assembled surface rapsyn-AChR complexes, it is as such not
required for agrin-induced clustering. Rather, our present data
show that the critical events for AChR clustering occur inde-
pendently of secretion at the plasma membrane, where agrin
regulates the extent of interaction between a free pool of rapsyn
(17) and surface AChRs (Fig. 9).
The agrin-induced increase in rapsyn-AChR interaction
could potentially reflect de novo formation of more rapsyn-
AChR complexes, higher affinity binding between rapsyn and
the AChR, or more rapsyn molecules bound per individual
AChR. The formation of additional 1:1 rapsyn-AChR complexes
(or the stabilization of such complexes) seems possible, as the
AChR and rapsyn have been shown to be present in approxi-
mately equimolar amounts in Torpedo electric organ and in
cultured muscle cells (34). Ultrastructural studies also support
a 1:1 stoichiometry and a direct interaction between rapsyn
and AChRs (35, 36). On the other hand, the precise ratio of
rapsyn to AChR in clusters remains to be determined and our
increased rapsyn-AChR interaction may reflect binding of more
rapsyn molecules to each AChR. If this is the case, the addi-
tional rapsyn would necessarily bind at a different site on the
AChR, creating a distinct form of rapsyn-AChR complex with a
2:1 stoichiometry (see Fig. 9). Interestingly, it has been shown
that the expression ratio of rapsyn to AChR is critical for
clustering (19) and that this expression ratio is lower extrasyn-
aptically than at the NMJ (37). Our data are consistent with
these studies and indicate that it is an increase in the associ-
ation ratio of rapsyn to AChR at the surface that is likely to
trigger clustering.
This notion is supported by our observation that the agrin-
induced increase in rapsyn-AChR interaction correlated
strongly with AChR clustering in several different experimen-
tal conditions. First, in S27 cells, agrin, even at high concen-
trations, failed to induce increased interaction as well as clus-
tering. Second and third, herbimycin and staurosporine
blocked both the agrin-induced increase in the rapsyn-AChR
interaction and AChR clustering in C2 cells. Herbimycin inhib-
its agrin-induced phosphorylation of MuSK, while staurospo-3 M. Moransard and C. Fuhrer, unpublished data.
FIG. 9. Model for AChR clustering
driven by agrin-induced changes in
rapsyn-AChR interaction that in-
crease cytoskeletal linkage. In the ab-
sence of agrin, pre-assembled rapsyn-
AChR complexes at the plasma
membrane are presumably the result of
insertion of intracellular complexes (open
arrows). Such complexes are mostly un-
clustered (step 1). Agrin treatment (black
arrows) induces an increase in the inter-
action of rapsyn with surface AChRs,
which strengthens linkage of AChRs to
the cytoskeleton. This increase appears to
be necessary for clustering and originates
from a non-secretory mechanism, most
likely by recruitment of rapsyn from a
non-receptor-associated free pool. Both
the increased rapsyn-surface AChR inter-
action and cytoskeletal linkage precede
clustering. For simplicity, possible mem-
brane association of free rapsyn is ne-
glected. For further details, see
“Discussion.”
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rine blocks a kinase downstream of MuSK, possibly a member
of the Src-family (21, 23). Thus, our results suggest that such a
kinase may regulate rapsyn-AChR interactions downstream of
MuSK activation. Fourth, the agrin-induced increase in rapsyn
interaction occurs rapidly (within 40 min in C2), and parallels
early signaling events that are important for the subsequent
clustering of the AChR, such as tyrosine phosphorylation of the
AChR  subunit (22). This temporal correlation raises the
possibility that rapsyn binding to the AChR is regulated by 
subunit phosphorylation, and that they are linked precursor
steps in the clustering pathway, a hypothesis we are currently
investigating. Fifth, laminin-1, which is thought to act inde-
pendently of MuSK in AChR clustering (27, 28), also leads to
increased rapsyn-AChR interaction. Sixth, extracellular Ca2,
which acts via MuSK to induce AChR -subunit phosphoryla-
tion and receptor clustering (29), induces a similar increase in
rapsyn-AChR binding. Finally, agrin-induced rapsyn-AChR in-
teractions and clustering still occur at 20 °C, when secretion
and new AChR insertion into the plasma membrane are
blocked. This shows that the events critical for clustering occur
at the cell surface and suggests that increased interaction of
rapsyn with surface AChRs may be sufficient to drive cluster-
ing in the absence of secretion.
Rapsyn has long been proposed to mediate a cytoskeletal link
of the AChR. For example, extraction of rapsyn from clusters
on rat myotubes or from Torpedo electrocytes increases AChR
mobility in the membrane (38, 39). Furthermore, rapsyn medi-
ates interaction of AChRs with the dystrophin/utrophin glyco-
protein complex, which binds to F-actin (15). We now demon-
strate that rapsyn is preferentially associated with AChRs that
are bound to the cytoskeleton, and that the agrin-induced in-
crease in interaction of rapsyn with AChRs correlates strongly
with increased cytoskeletal linkage of the AChR. This in-
creased cytoskeletal linkage occurs in parallel with AChR-
associated signaling events (such as tyrosine phosphorylation
of AChRs, of AChR-bound MuSK, and Src-type kinases (21)),
and precedes detectable clustering of the AChR. The emerging
picture is thus that the AChR acts as a scaffold onto which
anchoring proteins like rapsyn and several signaling proteins
are rapidly recruited by agrin. Within the resulting AChR-
protein complexes, rapsyn appears as the most abundant
postsynaptic protein based on its high expression level (34) and
its much higher extent of binding to the AChR relative to other
postsynaptic components (15). Together, these observations
strongly imply that it is the increased rapsyn-AChR interaction
that enhances the cytoskeletal anchoring of the AChR in the
postsynaptic membrane, and so promotes AChR clustering.
In summary, the data presented here, together with our
previous studies (17), suggest a model for AChR clustering in
which pre-assembled, unclustered AChR-rapsyn complexes oc-
cur at the plasma membrane and are required for subsequent
clustering (Fig. 9, step 1). Neural agrin, released by the nerve
terminal, then signals through MuSK and further increases
the interaction of rapsyn and the AChR in the postsynaptic
membrane, either by increasing the number of AChR-rapsyn
complexes or by increasing the amount of rapsyn interacting
with an individual AChR. This occurs through a kinase-de-
pendent step, independently of the secretory pathway, and by
recruitment of rapsyn from a free pool. We propose that the
increased rapsyn-AChR association then leads to enhanced
cytoskeletal linkage, and to the progressive postsynaptic clus-
tering of the AChR (Fig. 9, step 2).
Pre-assembly of postsynaptic complexes may also play a role
in formation of central synapses. At excitatory synapses in
hippocampal neurons, clusters of PSD-95 first appear in den-
dritic shafts or dynamic spine precursors before moving,
through cytoskeletal rearrangement, to their final position in
the mature spine head (40). At inhibitory synapses, much like
AChRs and rapsyn at the NMJ, gephyrin and -aminobutyric
acid type A (GABAA) receptors are mutually important for
clustering, most likely by forming interdependent components
of a protein complex (41). Our data substantiate the possibility
that postsynaptic specializations of synapses are in general
constructed from pre-assembled complexes of their compo-
nents. Such pre-assembly may ensure that postsynaptic mem-
branes can be formed and modified rapidly according to phys-
iological needs.
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